Robert Schlaberg

Robert Schlaberg, MD, Dr. med., MPH is a medical director at ARUP Laboratories, an assistant professor of Pathology at the University of Utah, and a co-founder of IDbyDNA Inc. He completed his Clinical Pathology residency and Master of Public Health training at Columbia University, and a Medical Microbiology fellowship at ARUP Laboratories. His research is focused on next-generation sequencing-based infectious disease diagnostics and is supported in part by the Bill & Melinda Gates Foundation. He has co-developed Taxonomer, an ultrafast, user-friendly, web-based metagenomics data analysis tool with the goal of bringing precision medicine to infectious disease diagnosis. He is board-certified in Clinical Pathology and Medical Microbiology by the American Board of Pathology. He is a member of the College of American Pathologists’ Microbiology Resource Committee and Standard Committee.

Education

• Master of Public Health (M.P.H.) Columbia University in the City of New York (2006 — 2008)
• Dr. med. The Julius Maximilians University of Würzburg (1997 — 2004)
• Doctor of Medicine (M.D.) The Julius Maximilians University of Würzburg (1997 — 2003)

Companies

• Distinguished Scientist, Infectious Disease and VP at Illumina Illumina (2022)
• Member The Alliance To End Biological Threats (2020)
• Co-Founder, Chief Medical Officer IDbyDNA Inc. (2015 — 2022)
• Adjunct Assistant Professor University of Utah School of Medicine (2019 — 2022)
• Medical Director, Infectious Diseases ARUP Laboratories (2012 — 2019)
• Medical Director, Infectious Diseases ARUP Laboratories (2011 — 2019)
• Assistant Professor (Tenure Track) University of Utah School of Medicine (2015 — 2019)
• Member, Microbiology Resource Committee College of American Pathologists (CAP) (2013 — 2018)
• Member, Standards Committee College of American Pathologists (CAP) (2012 — 2017)